Patent · US Active

Modulators of the 5-hydroxytryptamine receptor 7 and their method of use

US10858368B2 · kind B2 · utility

5Cited by

0References

25Claims

0Family size

Assignees

Temple University-Of The Commonwealth System of Higher Education · US
Praeventix, LLC · US

Inventors

Daniel J. Canney · Ambler, US
Benjamin E. Blass · Eagleville, US
Kevin M. Blattner · Folsom, US
Douglas A. Pippin · Branford, US

Key dates

Filing date	Nov 15, 2017
Grant date	Dec 8, 2020
Priority date	—
Expiry date	Nov 15, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07F7/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.